PMCPA Case
| Case | AUTH/3788/6/23 |
| Company | AstraZeneca UK Limited |
| Complainant | Contactable complainant (health professional) |
| Material | Third-party publisher email newsletter “SPONSORED” content block linking to “See Beyond Sugar” microsite |
| Product referenced on microsite | Forxiga (dapagliflozin) |
| Main issue | Email did not name AstraZeneca and did not make clear the link led to promotional content; email advert not certified |
| Applicable Code year | 2021 |
| Complaint received | 30 June 2023 |
| Case completed | 23 July 2024 |
| Appeal | No appeal |
| Breach clauses | Clause 3.6; Clause 5.5; Clause 8.1 |
| No breach clauses | Clause 5.1 |
| Sanctions | Undertaking received |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
One real case. One key lesson. Every week — free.